ClassID:

94215

C07D213/42 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms; Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Recent Application in this class:
#1
20260152470
2026-06-04

SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS

#2
20250340510
2025-11-06

Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof

#3
20250162993
2025-05-22

SYNTHESIS OF THE RADIOLABELED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR [18F]DCFPYL

#4
20240425450
2024-12-26

SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS

#5
20240366595
2024-11-07

PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS

#6
20240208906
2024-06-27

HYDROGENATION OF IMINES BY PALLADIUM BASED CATALYST

#7
20240101510
2024-03-28

APYRASE INHIBITORS

#8
20240043384
2024-02-08

INHIBITORS OF PU.1 FOR THE TREATMENT OF DISEASE

#9
20230357139
2023-11-09

SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS

#10
20230265055
2023-08-24

STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS

#11
20220396581
2022-12-15

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

#12
20220347176
2022-11-03

Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators

#13
20220227792
2022-07-21

CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY

#14
20220089555
2022-03-24

N-benzyl-N-arylsulfonamide derivative and preparation and use thereof

#15
20220081442
2022-03-17

3,6-disubstituted-2-pyridinaldoxime scaffolds

#16
20220055991
2022-02-24

Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [F]DCFPYL

#17
20210276967
2021-09-09

INHIBITORS OF HEPATITIS B VIRUS

#18
20210269399
2021-09-02

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#19
20210024462
2021-01-28

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#20
20200339591
2020-10-29

COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA

#21
20200299284
2020-09-24

Sulfonylureas and related compounds and use of same

#22
20200277268
2020-09-03

PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF

#23
20200270205
2020-08-27

Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N, N-dialkylanilines

#24
20200255373
2020-08-13

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#25
20200246286
2020-08-06

Imaging composition and uses thereof

#26
20200009090
2020-01-09

Imaging composition and uses thereof

#27
20190269719
2019-09-05

Polyguanidine polymers and methods of use thereof

#28
20190194135
2019-06-27

Modulators of the integrated stress pathway

#29
20190177275
2019-06-13

Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [F]DCFPyL

#30
20190169166
2019-06-06

Heterocyclic compound

#31
20190099392
2019-04-04

Imaging composition and uses thereof

#32
20180312468
2018-11-01

ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS

#33
20180291207
2018-10-11

Chromophores for photochromic compositions useful for three dimensional display applications

#34
20180141902
2018-05-24

Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N,N-dialkylanilines

#35
20180127361
2018-05-10

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#36
20180086697
2018-03-29

Inhibitors of human immunodeficiency virus replication

#37
20180071270
2018-03-15

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#38
20180057455
2018-03-01

Compounds useful as immunomodulators

#39
20170360041
2017-12-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

#40
20170326084
2017-11-16

Imaging composition and uses thereof

#41
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#42
20170224723
2017-08-10

Method for producing polyguanidines

#43
20170183315
2017-06-29

Selective inhibitors interfering with fibroblast growth factor receptor and FRS2 interaction for the prevention and treatment of cancer and other diseases

#44
20170044373
2017-02-16

Chromophores for photochromic compositions useful for three dimensional display applications

#45
20160318919
2016-11-03

Oxime-substituted amide compound and pest control agent

#46
20160271582
2016-09-22

Metal-organic materials and method for preparation

#47
20160205933
2016-07-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests

#48
20160131641
2016-05-12

Compounds and compositions for use as alkylating agent sensors and methods of use thereof

#49
20160060282
2016-03-03

Method for producing novel organometallic complex and amine compound

#50
20160052865
2016-02-25

Cyclopropylamine derivatives useful as LSD1 inhibitors

#51
20160031851
2016-02-04

Triazolinthione derivatives

#52
20160024049
2016-01-28

Heterocyclic compound

#53
20160002166
2016-01-07

Process for preparing atazanavir sulphate

#54
20150361039
2015-12-17

Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor

#55
20150315178
2015-11-05

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof

#56
20150266890
2015-09-24

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#57
20150238498
2015-08-27

Compounds for the treatment of paramoxyvirus viral infections

#58
20150210630
2015-07-30

Oxime-substituted amide compound and pest control agent

#59
20150183742
2015-07-02

Process for the preparation of atazanavir bisulfate

#60
20150105429
2015-04-16

BENZYL SULFONAMIDE DERIVATIVES AS RORC MODULATORS

#61
20150105427
2015-04-16

N-[1-((6-chloropyridin-3-yl) methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of animal parasitic pests and agricultural/horticultural pests

#62
20150038708
2015-02-05

Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein

#63
20140378466
2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

#64
20140343290
2014-11-20

PROCESS FOR THE PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT

#65
20140335019
2014-11-13

COMPOSITIONS AND METHODS FOR THE TREATMENT AND ANALYSIS OF NEUROLOGICAL DISORDERS

#66
20140243362
2014-08-28

Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor

#67
20140194605
2014-07-10

SERS Reporter Molecules and Methods

#68
20140187531
2014-07-03

Apoptosis promoters

#69
20140148453
2014-05-29

Sulfonamide compounds useful as CYP17 inhibitors

#70
20140031559
2014-01-30

Tunable phenylacetylene hosts

#71
20140031399
2014-01-30

Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors

#72
20130310384
2013-11-21

Sulfonamide-Containing Compounds

#73
20130310347
2013-11-21

MULTI-MODALITY MOLECULAR IMAGING HIGH-THROUGHPUT ASSAY FOR IDENTIFYING HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS

#74
20130225621
2013-08-29

Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein

#75
20130217887
2013-08-22

Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof

#76
20130197013
2013-08-01

Cyclopropylamine derivatives useful as LSD1 inhibitors

#77
20130190356
2013-07-25

BENZYL SULFONAMIDE DERIVATIVES AS RORC MODULATORS

#78
20130184241
2013-07-18

Naphthalene derivative

#79
20130183252
2013-07-18

COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME

#80
20130150414
2013-06-13

Pest control agent

#81
20130102609
2013-04-25

Biaryl oxyacetic acid compounds

#82
20130041156
2013-02-14

AZAPEPTIDE DERIVATIVES

#83
20130035493
2013-02-07

Process for preparing form A of atazanavir sulfate

#84
20130005780
2013-01-03

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF TAPENTADOL

#85
20120329786
2012-12-27

COMPOUNDS AND THERAPEUTIC USES THEREOF

#86
20120322749
2012-12-20

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#87
20120309648
2012-12-06

INTEGRATED MICROFLUIDICS FOR HIGHLY PARALLEL SCREENING OF CHEMICAL REACTIONS

#88
20120282180
2012-11-08

Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof

#89
20120225882
2012-09-06

Selective hydroxamate based MMP inhibitors

#90
20120190098
2012-07-26

Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems

#91
20120165288
2012-06-28

Azapeptide derivatives

#92
20120157687
2012-06-21

IMPROVED PROCESS FOR THE PREPARATION OF ARYLPYRIDINYL COMPOUNDS

#93
20120156491
2012-06-21

SERS Reporter Molecules and Methods

#94
20120095024
2012-04-19

TOLUIDINE SULFONAMIDES AND THEIR USE

#95
20120094964
2012-04-19

SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS

#96
20120092085
2012-04-19

Poly-phase filter, and a single-side band mixer including the same

#97
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

#98
20120015987
2012-01-19

Polymorph of atazanavir sulfate

#99
20110306493
2011-12-15

Sulfoximinamide compounds for combating animal pests

#100
20110281837
2011-11-17

3-SUBSTITUTED-6-ARYL PYRIDINES

#101
20110256129
2011-10-20

Apoptosis promoters

#102
20110230350
2011-09-22

ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS

#103
20110207937
2011-08-25

Compounds that inhibit (block) bitter taste in composition and methods of making same

#104
20110144112
2011-06-16

Apoptosis promoters

#105
20110130426
2011-06-02

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#106
20110130283
2011-06-02

Substituted Pyridin-4-ylmethyl Sulfonamides

#107
20110124689
2011-05-26

Process for preparing atazanavir bisulfate and novel forms

#108
20110112076
2011-05-12

SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS

#109
20110105485
2011-05-05

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

#110
20110065578
2011-03-17

Substituted Pyridin-4-ylmethyl Sulfonamides

#111
20110059940
2011-03-10

2-Aryl Glycinamide Derivatives

#112
20110028509
2011-02-03

Sulfonamides

#113
20110009355
2011-01-13

Azapeptide derivatives

#114
20100256202
2010-10-07

5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof

#115
20100234364
2010-09-16

CCR2 INHIBITORS AND METHODS OF USE THEREOF

#116
20100183716
2010-07-22

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#117
20100183715
2010-07-22

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#118
20100178340
2010-07-15

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#119
20100178339
2010-07-15

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

#120
20100056528
2010-03-04

Sulfonamide derivatives with therapeutic indications

#121
20100041892
2010-02-18

Therapeutic agent for diabetes

#122
20100029952
2010-02-04

Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems

#123
20090318511
2009-12-24

Selective hydroxamate based MMP inhibitors

#124
20090275556
2009-11-05

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

#125
20090274632
2009-11-05

Compounds that inhibit (block) bitter taste in composition and use thereof

#126
20090270631
2009-10-29

Therapeutic agent for diabetes

#127
20090247536
2009-10-01

Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use

#128
20090203699
2009-08-13

AMINOMETHYLPYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF

#129
20090203630
2009-08-13

Process for preparing atazanavir bisulfate and novel forms

#130
20090176980
2009-07-09

3-substituted-6-aryl pyridines

#131
20090176773
2009-07-09

Non-Peptidic Inhibitors of AKAP/PKA Interaction

#132
20090093485
2009-04-09

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#133
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#134
20090076097
2009-03-19

DEUTERIUM-ENRICHED ATAZANAVIR

#135
20090069282
2009-03-12

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

#136
20090048224
2009-02-19

COMPOUNDS AND METHODS OF USE

#137
20090036357
2009-02-05

Azapeptide derivatives

#138
20080275127
2008-11-06

Arylsulfonamido-substituted hydroxamic acid derivatives

#139
20080249102
2008-10-09

HIV protease inhibitors

#140
20080242656
2008-10-02

N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof

#141
20080227858
2008-09-18

Inhibitors of matrix metalloproteinase

#142
20080221177
2008-09-11

4- PIRIDINYLMETHYLSULPHONAMIDE DERIVATIVE AS FUNGICIDAL PLANT PROTECTION AGENTS

#143
20080214394
2008-09-04

N-(4-Pyridyl)Methylsulfonamides For Combating Arthropodal Pests

#144
20080194648
2008-08-14

Compounds which potentiate glutamate receptor and uses thereof in medicine

#145
20080194520
2008-08-14

Sulfonyl amino cyclic derivatives and use thereof

#146
20080167351
2008-07-10

Compounds which potentiate glutamate receptor and uses thereof in medicine

#147
20080167348
2008-07-10

Sulfonamide derivatives

#148
20080161401
2008-07-03

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#149
20080161187
2008-07-03

Biphenyl-N-(4-Pyridyl) Methylsulfonamides

#150
20080090794
2008-04-17

Potassium channel inhibitors

#151
20080085894
2008-04-10

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

#152
20080058382
2008-03-06

Polyamine compounds

#153
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#154
20080021070
2008-01-24

PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF

#155
20080009530
2008-01-10

Therapeutic Agent for Diabetes

#156
20070203245
2007-08-30

ABCA1 elevating compounds

#157
20070197522
2007-08-23

Dpp-iv inhibitors

#158
20070185136
2007-08-09

Sulphonamide derivatives, their preparation and their therapeutic application

#159
20070167631
2007-07-19

Novel herbicides

#160
20070161638
2007-07-12

Compounds which potentiate glutamate receptor and uses thereof in medicine

#161
20070142641
2007-06-21

Atazanavir conjugates and antibodies useful in immunoassay

#162
20070072860
2007-03-29

Apoptosis promoters

#163
20070015787
2007-01-18

Apoptosis promoters

#164
20070009819
2007-01-11

Novel compound, and electrophotographic photoreceptor and electrophotographic apparatus made by using the same

#165
20070004806
2007-01-04

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#166
20060293314
2006-12-28

4-Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents

#167
20060276493
2006-12-07

α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#168
20060276464
2006-12-07

Diarylsulfone sulfonamides and use thereof

#169
20060160820
2006-07-20

Substituted piperazine carbamates

#170
20060142385
2006-06-29

Inhibitors of matrix metalloproteinase

#171
20060128765
2006-06-15

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

#172
20060128762
2006-06-15

Medicinal composition and method for treating malignant tumor and utilization thereof

#173
20060122239
2006-06-08

Arylsulfonamidobenzylic compounds

#174
20060116410
2006-06-01

4-Aminomethyl benzamidine derivatives

#175
20060106089
2006-05-18

Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

#176
20060094789
2006-05-04

α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#177
20060052396
2006-03-09

Arylamines for the treatment of conditions associated with gsk-3

#178
20060030599
2006-02-09

Sulphonamide derivatives

#179
20060030595
2006-02-09

Potassium channel inhibitors

#180
20060020009
2006-01-26

Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#181
20050282905
2005-12-22

Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient

#182
20050267171
2005-12-01

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#183
20050256314
2005-11-17

Process employing controlled crystallization in forming crystals of a pharmaceutical

#184
20050256202
2005-11-17

Process for preparing atazanavir bisulfate and novel forms

#185
20050228017
2005-10-13

Novel anticancer compounds

#186
20050222146
2005-10-06

N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof

#187
20050215645
2005-09-29

Amide derivatives

#188
20050124654
2005-06-09

Compounds and methods of use

#189
20050113450
2005-05-26

Antibacterial agents

#190
20050107445
2005-05-19

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#191
20050085518
2005-04-21

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

#192
20050085515
2005-04-21

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#193
20050064517
2005-03-24

Methods of inhibiting transmission of a costimulatory signal of lymphocytes

#194
20050043366
2005-02-24

Polyamine compounds for treating chemokine receptor mediated diseases

#195
20050014840
2005-01-20

Thiol sulfonamide metalloprotease inhibitors

#196
20050014787
2005-01-20

5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof

#197
20050009871
2005-01-13

Ubiquitin ligase inhibitors